Journal article icon

Journal article

Tolerability and safety profile of cariprazine in treating psychotic disorders, bipolar disorder and major depressive disorder: a systematic review with meta-analysis of randomized controlled trials

Abstract:
Background Cariprazine is a novel antipsychotic agent recently approved for treating schizophrenia and bipolar mania in the USA. The sample sizes of published randomized controlled trials (RCTs) of the drug are small; previous meta-analyses included few RCTs and did not specifically investigate the tolerability/safety profile of cariprazine. Objective Our objective was to conduct a meta-analysis of published RCTs to systematically review the tolerability and... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1007/s40263-016-0382-z

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Subgroup:
Botnar Research Centre
Role:
Author
Publisher:
Springer International Publishing Publisher's website
Journal:
CNS Drugs Journal website
Volume:
30
Issue:
11
Pages:
1043-1054
Publication date:
2016-08-22
Acceptance date:
2016-08-08
DOI:
EISSN:
1179-1934
ISSN:
1172-7047
Pubs id:
pubs:942923
URN:
uri:b22e97ee-5fbb-4808-9be9-6b3f46cc4e88
UUID:
uuid:b22e97ee-5fbb-4808-9be9-6b3f46cc4e88
Local pid:
pubs:942923

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP